Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Secured cards can be reported to bureaus quickly, affecting your score as activity is recorded. Learn timing and how to monitor updates.
9,942 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Aurora Innovation saw a dramatic rally in the first half of 2026. This article explores the factors behind the move, ...
A one-time lottery windfall can trigger IRMAA surcharges, lifting Medicare premiums for the following year. Here's ho...
A prominent crypto researcher questions whether using iphone safer than a hardware wallet for signing transactions, f...
Boeing’s June performance marks more than a monthly milestone. With 64 jets delivered, the company nudges its cash fl...
Tech stocks lead a broad market pullback as AI costs rise and Netflix guidance misses, sending the Nasdaq Composite l...
Alphabet’s cloud momentum is reshaping the risk-and-reward profile for investors. This article explains why the googl...
As tesla heads into july, the market faces a tug-of-war: robust quarterly deliveries versus pressure on margins and a...
Foreign R&D drives innovation across borders, but it carries subtle tax costs that can eat into profits. This guide e...
In a year of sharp rotation, the Vanguard FTSE DEVELOPED Markets ETF ex US is outperforming the S&P 500—yet the decad...